Hi
We are a c/s 5.65 site and are having discussions as to what we should populate in the TRADE NAME field of the drug dictionary. Should it be populated with the trade name for ALL formulary items even if we only stock the generic equivalent or should it be left blank for those items that we only stock the generic equivalent of that drug??
Patrick J. O'Donnell, RPh
Cell: 570-926-9049
I’ve always had the real trade names there because even for generic products where the trade name is no longer made, physicians will still order by trade name. Also, you want both names on the e-MAR and in CPOE. You should also use generic equivalent field if you have more than one trade name. For instance, I have Zestril,Prinivil in the trade name field and then Prinivil for a generic equivalent.
Charlie
Charles Downs PharmD
Information Systems Pharmacist
Meritus Health, Inc.
11116 Medical Campus Road
Hagerstown, MD, 21742

I recommend entering the most common trade name in the Trade Name field, and any alternative names in the Generic Equivalent field as Charlie suggests. The only difference is that I would only enter one name in the Trade Name field instead of Zestril,Prinivil. The physicians still order by trade name and in CPOE they will search for drugs by the trade name. To address Richard’s concern, you are not dispensing the drug as the Trade, only using it as an internal reference. Entering the generic name in the trade name field is redundant since the generic is already used as a lookup. For labels, they are all customizable and can print either Trade, Generic, or both names.
The only time I would recommend deviating from entering a Trade Name would be in the instance of a “placeholder” type drug entry such as OWN MED or NON-FORM. For any placeholder drug entries the Trade Name field should be left blank so the RX ID (which should be edited at order entry) will be used in the EMR and eMAR.
Sincerely,
Raymond Fernandez
Dearborn Advisors, LLC
cell: 361-549-2999
fax: 1-636-212-9076
We use a trade name + “Equiv.” in the Trade Name field to denote we are not actually dispensing the trade name product.
Alex Ivanyisky, RPh
Pharmacy Informatics Coordinator
Woman's Hospital Pharmacy Dept
Baton Rouge, LA

I understand your point and swam upstream against the design for years. With desktop eMAR and CPOE, I finally caved and went with the flow (most common trade name or historical trade name). Of course, we have custom label outputs so we don’t have to misbrand our products, especially for outpatient dispensing.
This is in PHA only. I continue to resist updating 29,000+ drugs manually in RXM (with about 250 new items each month).
Jeff
From: meditech-...@mtusers.com [mailto:meditech-...@mtusers.com] On Behalf Of RPlo...@stmarysmaine.com
Sent: Wednesday, May 16, 2012 6:26 AM
To: Charles Downs
Cc: meditech-...@mtusers.com; medit...@mtusers.com
I’ve asked the same. If I were designing RXM, I’d have one drug mnemonic entry for each GPC from FDB, then use a multiple field for Trade Name and NDC (just like PHA, imagine).
I think they are planning a “common orderable” where the site has to create and maintain one selected representative of the GPC for each drug…then the user search would like to the “common orderable tier first so that look-ups are smaller and you’re likely to have drugs selected you know map over to PHA, have strings, etc…however, this just seems like a much more labor intensive maintenance design.
Jeff
From: Charles Downs [mailto:Charle...@meritushealth.com]
Sent: Wednesday, May 16, 2012 9:11 AM
To: Jeff Lee; RPlo...@stmarysmaine.com
Cc: meditech-...@mtusers.com; medit...@mtusers.com
Subject: RE: [MT-L] Trade name field in drug dictionary
As an added not, do not change a generic name to a trade name in RXM or it will keep creating new entries as it thinks that the generic entry does not exist and you will wind up with duplicates. We took a bunch of DTS’s to fix some other issues and it may have corrected this. The problem you run into in RXM is that some trade names are no longer available and it is just the generic, but there is no generic equivalent in RXM. I’ve asked Mark Donovan to look at this and to try to create a generic equivalent field in RXM.
Charlie
As an added not, do not change a generic name to a trade name in RXM or it will keep creating new entries as it thinks that the generic entry does not exist and you will wind up with duplicates. We took a bunch of DTS’s to fix some other issues and it may have corrected this. The problem you run into in RXM is that some trade names are no longer available and it is just the generic, but there is no generic equivalent in RXM. I’ve asked Mark Donovan to look at this and to try to create a generic equivalent field in RXM.
Charlie
From: Jeff Lee [mailto:JL...@dchsystem.com]
Sent: Wednesday, May 16, 2012 10:05 AM
If there are more than two trade names for a product, having them both in the trade name field is helpful for the nurses checking their e-MAR versus written orders. This probably wouldn’t be an issue once you are 100% CPOE. The other option, and I know that some states require this, is to put something like Zestril Sub, or Subtituted for Zestril. Here in Maryland, we’ve never had this problem. I believe that it would be wise to check with you state board of pharmacy to see what they want to see. Also, you need to see how this relates to a trade name being used on a generic when prepacking, on labels, on the e-MAR, and as look-ups as they may have different legal interpretations.
Thanks,
Charlie
Charles Downs PharmD
Information Systems Pharmacist
Meritus Health, Inc.
11116 Medical Campus Road
Hagerstown, MD, 21742

[MAGIC] Oh. Forgot to mention previously that most if not all of POM trade name displays come from the trade name field in QuickScripts, not PHA. When it comes to POM searching, there is also a “generic equivalent-equivalent” multiple field.
From: meditech-...@mtusers.com [mailto:meditech-...@mtusers.com] On Behalf Of Ray Fernandez
Sent: Wednesday, May 16, 2012 7:43 AM
Thank goodness 6.1 is putting LSS into the MEDITECH HCIS so we’ll all be back to 1 set of unmanageable PHA and RXM Drug dictionaries!
But aside from that, heads up that for our CS 5.6.4 pp 21 sites we are having to get CS RXM 4587 because the free text names that were added to the PHA Drug dictionary are overwriting the FSV trade name that is loading into RXM. So before making wholesale changes to the PHA trade names you might want to verify that isn’t affecting your RXM Drug dictionary during your FSV updates. (We use Medispan but this seems to be vendor-blind)
**************
Message: 5
Date: Thu, 17 May 2012 22:56:56 -0500
From: david watson <dwat...@gmail.com>
Subject: [MT-L] Trade name field in drug dictionary
Message-ID:
<CAP+v7PqBd+OC7WkOd3hG+kxf...@mail.gmail.com>
Content-Type: text/plain; charset="iso-8859-1"
From: Charles Downs <Charle...@meritushealth.com>
|
|
Jennifer F Miller, Masters Training & Development |
Somewhere along the line, we got a CDS on page 1 of RXM that tells us the GPC. I guess my analyst did this, but I believe that Meditech told him how to. I had asked Mark Donovan if it was possible also to see the FSV trade and generic name in a CDS but haven’t heard anything. We are FDB, and they sent me a nice searchable spreadsheet with every drug on our CD. Maybe Medispan could do the same. The spreadsheet was especially helpful in identifying obsolete drugs, which hang out there for at least 3 years and also repackager NDC’s. Mark said that they are going to try to address the obsolete NDC issue as it creates a lot of duplicates. For instance Mylicon Drops is now obsolete and is now under Infants’ Mylicon. And good luck to someone finding that (which is why we need a generic equivalent field in RXM)
Charlie
Charles Downs PharmD
Information Systems Pharmacist
Meritus Health, Inc.
11116 Medical Campus Road
Hagerstown, MD, 21742

From: Griffin, Paul [mailto:PGri...@emersonhosp.org]
Sent: Monday, May 21, 2012 9:23 AM
To: Jeff Lee; Ray Fernandez; RPlo...@stmarysmaine.com; Charles Downs
Subject: RE: [MT-L] Trade name field in drug dictionary
Hello fellow pharmacists (Ray, I know you are a pharmacy tech, but in IS, you are the same as the rest of us: Stuck with an inferior product that no one other than us will ever understand) L
We went LIVE with RXM on March 17th. To this day we are still having major issues. We have the old standby for our FSV (Medi-Span), which as we know is designed for community pharmacy doctored up for hospital pharmacy.
Anyhow, before I sound like a blogger on TAP, what’s the easiest way to identify a GPC for a particular medication? I have been using a variety of ways to do this, but if there’s a better way, please sound off!
Thanks,
Paul
p.s. Oh, we are MG 5.64 PP12.
P
Please consider the impact to the environment before printing this
email.
P
Please consider the impact to the environment before printing this
email.
To unsubscribe from the meditech-l, follow the instructions at the URL
http://mtusers.com/mailman/options/meditech-l_mtusers.com/
I don’t know if has been fixed or not, but if you change the generic name (e.g.: remove reference to the salt), it seems to sometimes create duplicate RXM entries. I also saw this happen with 6x. I’ve asked Mark Donovan at Meditech if they could create an FSV trade field and generic field where the raw FSV names could be stored to avoid this, but have heard nothing further. I we had these two extra fields where the load would check and update these fields but protect our own fields, it should eliminate the problem. Also, it would be a good check to see what they use to replace and NDC as I’ve found discontinued NDC’s that have been replaced are sometimes replaced with an NDC with an entirely different trade name, sometimes resulting in the same NDC being used multiple times, when in fact that product has actually been discontinued.
This message and any included attachments are from NOVANT HEALTH INC. and are intended only for the addressee(s). The information contained herein may include trade secrets or privileged or otherwise confidential information. Unauthorized review, forwarding, printing, copying, distributing, or using such information is strictly prohibited and may be unlawful. If you received this message in error, or have reason to believe you are not authorized to receive it, please promptly delete this message and notify the sender by e-mail. If you believe that any information contained in this message is disparaging or harassing or if you find it objectionable please contact Novant Health, Inc. at 1-800-350-0094 or forward the e-mail to rep...@novanthealth.org. Thank you.